Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial

被引:1
作者
Bobb, Jennifer F. [1 ]
Idu, Abisola E. [1 ]
Qiu, Hongxiang [1 ]
Yu, Onchee [1 ]
Boudreau, Denise M. [1 ]
Wartko, Paige D. [1 ]
Matthews, Abigail G. [2 ]
McCormack, Jennifer [2 ]
Lee, Amy K. [1 ]
Campbell, Cynthia I. [3 ]
Saxon, Andrew J. [4 ]
Liu, David S. [5 ]
Altschuler, Andrea [3 ]
Samet, Jeffrey H. [6 ]
Northrup, Thomas F. [7 ]
Braciszewski, Jordan M. [8 ]
Murphy, Mark T. [9 ]
Arnsten, Julia H. [10 ,11 ]
Cunningham, Chinazo O. [11 ]
Horigian, Viviana E. [12 ]
Szapocznik, Jose [12 ]
Glass, Joseph E. [1 ]
Caldeiro, Ryan M. [13 ]
Tsui, Judith I. [14 ]
Burganowski, Rachael P.
Weinstein, Zoe M.
Murphy, Sean M. [15 ]
Hyun, Noorie [1 ]
Bradley, Katharine A. [1 ]
机构
[1] Kaiser Permanente Washington Hlth Res Inst, 1730 Minor Ave, Suite 1600, Seattle, WA 98101 USA
[2] Emmes Co, 401 N Washington St, Suite 700, Rockville, MD 20850 USA
[3] Kaiser Permanente Northern Calif Div Res, 2000 Broadway, Oakland, CA 94612 USA
[4] VA Puget Sound Hlth Care Syst, Ctr Excellence Subst Addict Treatment & Educ CESAT, 1660 S Columbian Way, Seattle, WA 98108 USA
[5] Natl Inst Drug Abuse Ctr Clin Trials Network, Three White Flint North, 11601 Landsdown St, North Bethesda, MD 20852 USA
[6] Boston Univ, Boston Med Ctr, Sch Med & Publ Hlth, Crosstown Ctr, 801 Massachusetts Ave, Boston, MA 02119 USA
[7] UTHlth Houston McGovern Med Sch, Dept Family & Community Med, 6431 Fannin St, Houston, TX 77030 USA
[8] Ctr Hlth Policy & Hlth Serv Res, Henry Ford Hlth, One Ford Pl,Suite 5E, Detroit, MI 48202 USA
[9] MultiCare Hlth Syst, 315 Martin Luther King Jr Way, Tacoma, WA 98415 USA
[10] Montefiore Med Ctr, 111 East 210 St, Bronx, NY 10467 USA
[11] Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA
[12] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, 1120 NW 14th St,10th Floor, Miami, FL 33136 USA
[13] Kaiser Permanente Washington, Mental Hlth & Wellness Dept, 1200 SW 27th St, Renton, WA 98057 USA
[14] Univ Washington, Sch Med, Dept Med, Div Gen Internal Med, 1959 NE Pacific St, Seattle, WA 98195 USA
[15] Weill Cornell Med Coll, Dept Populat Hlth Sci, 1300 York Ave, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
Opioid use disorder; Primary care; Cluster -randomized trial; Massachusetts Model; Implementation trial; Office -based addiction treatment; TERM BUPRENORPHINE TREATMENT; COLLABORATIVE CARE;
D O I
10.1016/j.drugalcdep.2024.111350
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Patients with opioid use disorder (OUD) have increased emergency and hospital utilization. The PROUD trial showed that implementation of office -based addiction treatment (OBAT) increased OUD medication treatment compared to usual care, but did not decrease acute care utilization in patients with OUD documented pre -randomization (clinicaltrials.gov/study/NCT03407638). This paper reports secondary emergency and hospital utilization outcomes in patients with documented OUD in the PROUD trial. Methods: This cluster -randomized implementation trial was conducted in 12 clinics from 6 diverse health systems (March 2015 -February 2020). Patients who visited trial clinics and had an OUD diagnosis within 3 years pre randomization were included in primary analyses; secondary analyses added patients with OUD who were new to the clinic or with newly -documented OUD post -randomization. Outcomes included days of emergency care and hospital utilization over 2 years post -randomization. Explanatory outcomes included measures of OUD treatment. Patient -level analyses used mixed -effect regression with clinic -specific random intercepts. Results: Among 1988 patients with documented OUD seen pre -randomization (mean age 49, 53 % female), days of emergency care or hospitalization did not differ between intervention and usual care; OUD treatment also did not differ. In secondary analyses among 1347 patients with OUD post -randomization, there remained no difference in emergency or hospital utilization despite intervention patients receiving 32.2 (95 % CI 4.7, 59.7) more days of OUD treatment relative to usual care. Conclusions: Implementation of OBAT did not reduce emergency or hospital utilization among patients with OUD, even in the sample with OUD first documented post -randomization in whom the intervention increased treatment.
引用
收藏
页数:9
相关论文
共 27 条
  • [1] Alford DP, 2011, ARCH INTERN MED, V171, P425, DOI 10.1001/archinternmed.2010.541
  • [2] Bobb J.F., 2019, Experimental Designs and Randomization Schemes: Designing to Avoid Identification Bias
  • [3] Addressing identification bias in the design and analysis of cluster-randomized pragmatic trials: a case study
    Bobb, Jennifer F.
    Qiu, Hongxiang
    Matthews, Abigail G.
    McCormack, Jennifer
    Bradley, Katharine A.
    [J]. TRIALS, 2020, 21 (01)
  • [4] Documented opioid use disorder and its treatment in primary care patients across six US health systems
    Boudreau, Denise M.
    Lapham, Gwen
    Johnson, Eric A.
    Bobb, Jennifer F.
    Matthews, Abigail G.
    McCormack, Jennifer
    Liu, David
    Campbell, Cynthia, I
    Rossom, Rebecca C.
    Binswanger, Ingrid A.
    Yarborough, Bobbi Jo
    Arnsten, Julia H.
    Cunningham, Chinazo O.
    Glass, Joseph E.
    Murphy, Mark T.
    Zare, Mohammad
    Hechter, Rulin C.
    Ahmedani, Brian
    Braciszewski, Jordan M.
    Horigian, Viviana E.
    Szapocznik, Jose
    Samet, Jeffrey H.
    Saxon, Andrew J.
    Schwartz, Robert P.
    Bradley, Katharine A.
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 112 : 41 - 48
  • [5] PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment
    Campbell, Cynthia I.
    Saxon, Andrew J.
    Boudreau, Denise M.
    Wartko, Paige D.
    Bobb, Jennifer F.
    Lee, Amy K.
    Matthews, Abigail G.
    McCormack, Jennifer
    Liu, David S.
    Addis, Megan
    Altschuler, Andrea
    Samet, Jeffrey H.
    LaBelle, Colleen T.
    Arnsten, Julia
    Caldeiro, Ryan M.
    Borst, Douglas T.
    Stotts, Angela L.
    Braciszewski, Jordan M.
    Szapocznik, Jose
    Bart, Gavin
    Schwartz, Robert P.
    McNeely, Jennifer
    Liebschutz, Jane M.
    Tsui, Judith I.
    Merrill, Joseph O.
    Glass, Joseph E.
    Lapham, Gwen T.
    Murphy, Sean M.
    Weinstein, Zoe M.
    Yarborough, Bobbi Jo H.
    Bradley, Katharine A.
    [J]. ADDICTION SCIENCE & CLINICAL PRACTICE, 2021, 16 (01)
  • [6] Clay Emilie, 2014, J Med Econ, V17, P626, DOI 10.3111/13696998.2014.925463
  • [7] Effectiveness-implementation Hybrid Designs Combining Elements of Clinical Effectiveness and Implementation Research to Enhance Public Health Impact
    Curran, Geoffrey M.
    Bauer, Mark
    Mittman, Brian
    Pyne, Jeffrey M.
    Stetler, Cheryl
    [J]. MEDICAL CARE, 2012, 50 (03) : 217 - 226
  • [8] Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program
    Gordon, Adam J.
    Lo-Ciganic, Wei-Hsuan
    Cochran, Gerald
    Gellad, Walid F.
    Cathers, Terri
    Kelley, David
    Donohue, Julie M.
    [J]. JOURNAL OF ADDICTION MEDICINE, 2015, 9 (06) : 470 - 477
  • [9] Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001-12
    Hsu, Douglas J.
    McCarthy, Ellen P.
    Stevens, Jennifer P.
    Mukamal, Kenneth J.
    [J]. ADDICTION, 2017, 112 (09) : 1558 - 1564
  • [10] Increased risk of type I errors in cluster randomised trials with small or medium numbers of clusters: a review, reanalysis, and simulation study
    Kahan, Brennan C.
    Forbes, Gordon
    Ali, Yunus
    Jairath, Vipul
    Bremner, Stephen
    Harhay, Michael O.
    Hooper, Richard
    Wright, Neil
    Eldridge, Sandra M.
    Leyrat, Clemence
    [J]. TRIALS, 2016, 17